CIK 0001816736 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · fiscal year ends 12/31
| FY2025 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Net income (USD) | -36.0 M | -40.8 M | ||
| Diluted EPS (USD/shares) | -6.01 | -45.05 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-20 | 144 | 144 | |
| 2026-10-20 | 144 | 144 | |
| 2026-10-20 | 144 | 144 | |
| 2026-10-20 | 144 | 144 | |
| 2026-10-20 | 424B5 | 424B5 | |
| 2026-10-19 | 144 | 144 | |
| 2026-10-19 | 144 | 144 | |
| 2026-10-19 | 144 | 144 | |
| 2026-10-19 | 144 | 144 | |
| 2026-10-19 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-10-19 |
| 2026-09-16 | 4 | 4 | 2026-09-15 |
| 2026-09-15 | 4 | 4 | 2026-09-11 |
| 2026-09-11 | 144 | 144 | |
| 2026-09-10 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-09-09 |
| 2026-09-09 | 4 | 4 | 2026-09-04 |
| 2026-09-04 | 144 | 144 | |
| 2026-09-04 | 144 | 144 | |
| 2026-09-04 | 144 | 144 | |
| 2026-09-04 | 144 | 144 | |
| 2026-09-03 | 4 | 4 | 2026-09-01 |
| 2026-09-03 | 144 | 144 | |
| 2026-09-03 | 144 | 144 | |
| 2026-09-03 | 144 | 144 | |
| 2026-09-03 | 144 | 144 | |
| 2026-09-02 | 144 | 144 |
Forms on file (last 1,000): 4 228, 144 162, 8-K 93, 3 47, SC 13G 20, 10-Q 18, SC 13G/A 17, SC 13D/A 16. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=IRON (0.002 USD), /gw/filings/filings?ticker=IRON&form=8-K, /gw/filings/facts?ticker=IRON&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange